The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RE(TM) initiative to engage key U.S. healthcare ...

The Family Heart Foundation, a non-profit research and advocacy organization to lead research and education, focusing on genetic dyslipidemias, has launched the Lp(a) AW(a)RE initiative to engage key ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a ...

Please provide your email address to receive an email when new articles are posted on . High levels of lipoprotein(a) are associated with elevated risk for an adverse heart event. The relationship was ...

Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested ...

A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, Wake Forest University ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Elevated levels of lipoprotein(a) [Lp(a)] were associated with significantly increased risks for incident peripheral artery disease and carotid artery stenosis. Among patients with peripheral artery ...

A new three-pronged blood test can show which people have a nearly tripled risk of heart attack. The test looks for two measures of cholesterol and one measure of i ...